NCT05861687View on ClinicalTrials.gov

Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 7, 2021

Study Completion Date

May 20, 2022

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole

Administered once a day per-oral (PO) with the dose of 0.4 mg/kg

DRUG

Lansoprazole

Administered once a day per-oral (PO) with the dose of 15 mg if individual's body mass was \<30 kg, and 30 mg if it was \>30 kg

DRUG

Amoxicillin

Administered thrice a day per-oral (PO) with the dose of 25 mg/kg

DRUG

Clarithromycin

Administered twice a day per-oral with the dose of 7.5 mg/kg

Trial Locations (2)

20124

Universitas Sumatera Utara General Hospital, Medan

20136

Haji Adam Malik General Hospital, Medan

All Listed Sponsors
lead

Finni Kollins

OTHER

NCT05861687 - Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children | Biotech Hunter | Biotech Hunter